Oct 2026· Journal of Clinical Medicine· Vol 15, pp. 7998· 0 citations· 25 references
Medicine
TL;DR
B7-H3 is frequently expressed in PM and was associated with poorer survival, including after adjustment for disease stage, which supports further investigation of B7-H3 as a potential prognostic biomarker and therapeutic target in PM.
Abstract
Background: Pleural mesothelioma (PM) is an aggressive malignancy with considerable biological heterogeneity and few established prognostic biomarkers. We evaluated the clinicopathological and prognostic relevance of B7-H3, TROP2, and p16 expression in PM. Methods: This retrospective study included 50 patients with histologically confirmed PM diagnosed between 2016 and 2025. Immunohistochemical expression of B7-H3, TROP2, and p16 was evaluated using an immunoreactivity scoring system. Associations with clinicopathological features were examined, and overall survival (OS) and progression-free survival (PFS) were analyzed using Kaplan–Meier and Cox proportional hazards methods. Results: High B7-H3, TROP2, and p16 expression was observed in 78%, 18%, and 20% of tumors, respectively. High B7-H3 expression was significantly associated with asbestos exposure, chemotherapy, and tumor stage. Patients with high B7-H3 expression had shorter median OS (11.0 vs. 42.0 months; p < 0.001) and PFS (11.0 vs. 40.0 months; p = 0.004) than those with negative/low expression. Neither TROP2 nor p16 expression was significantly associated with survival. In a parsimonious multivariable Cox model, high B7-H3 expression remained significantly associated with poorer OS after adjustment for disease stage (HR = 4.42, 95% CI: 1.29–15.21, p = 0.018). Conclusions: B7-H3 is frequently expressed in PM and was associated with poorer survival, including after adjustment for disease stage. These findings support further investigation of B7-H3 as a potential prognostic biomarker and therapeutic target in PM.
AbstractAim: Gastrointestinal stromal tumors (GISTs) exhibit marked heterogeneous clinical behavior that is not fully captured by conventional risk classification systems. This study aimed to evaluate the prognostic significance of loss of p16 expression and EZH2 overexpression and their relationship with clinicopathol...
T. Toyran, K. Ateş, T. Köşeci et al.· Cukurova Anestezi ve Cerrahi...· 0 citations
PURPOSE
We evaluated whether B7-H3, particularly stromal B7-H3, is associated with clinical benefit from programmed cell death protein 1 (PD-1) blockade in gastric cancer (GC) and characterized the immune context underlying this association.
MATERIALS AND METHODS
B7-H3 expression was evaluated by conventional and mul...
Rui-Peng Wang, Yun-Wen Tao, Han-Qin Xuan et al.· Laboratory investigation; a...· 0 citations
Background and Aim: Endometrial cancer is considered one of the most common cancers of the female genital system, with endometrioid endometrial carcinoma (EEC) being the most common subtype. Valosin-containing protein (VCP), or p97, acts as an important regulator of cellular protein homeostasis and is thought to play a...
Triple-negative breast cancer (TNBC) is a heterogeneous and aggressive subtype with limited therapeutic targets. We retrospectively evaluated the expression of phosphatase and tensin homolog (PTEN) and transmembrane serine protease 4 (TMPRSS4) by immunohistochemistry in formalin-fixed, paraffin-embedded tumor tissues f...
W. Hou, Sheng Zhang, Xi Wei et al.· Life· 0 citations
Background Trophoblast cell surface antigen 2 (TROP2) is frequently expressed in solid tumors, including gastric cancer (GC) and gastroesophageal junction cancer (GEJC), but its distribution and clinical relevance remain unclear. Patients and methods We analyzed patients with GC/GEJC who underwent prospective multibiom...
Y. Tong, I. Nakayama, N. Sakamoto et al.· ESMO gastrointestinal oncolo...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.